Effects of excess dietary iron and fat on glucose and lipid metabolism

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1634-1644

  Choi, Joo Sun ^a   Koh, In Uk ^a   Lee, Hyo Jung ^a   Kim, Won Ho ^a   Song, Jihyun ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Hepatic steatosis; Hepcidin; High fat diet; Insulin resistance; Iron overload

Indexed keywords

CARBONYL IRON; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAT INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER FUNCTION; LOW FAT DIET; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PANCREAS FUNCTION;

MUS;

EID: 84881559017     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.02.004     Document Type: Article

References (41)

1. Munǒz M., García-Erce J.A., Remacha A.F. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol 2011, 64:281-286.
2. McClain D.A., Abraham D., Rogers J., Brady R., Gault P., Ajioka R., et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetelogia. 2006, 49:1661-1669.
3. Kim C.H., Kim H.K., Bae S.J., Park J.Y., Lee K.U. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism 2010, 60:414-420.
4. Ford E.S., Cogswell M.E. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999, 22:1978-1983.
5. Luan de C., Li H., Li S.J., Zhao Z., Li X., Liu Z.M. Body iron stores and dietary iron intake in relation to diabetes in adults in North China. Diabetes Care 2008, 31:285-286.
6. Sun L., Franco O.H., Hu F.B., Cai L., Yu Z., Li H., et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle aged and elderly Chinese. J Clin Endocrinol Metab 2008, 93:4690-4696.
7. Hramiak I.M., Finegood D.T., Adams P.C. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997, 20:110-118.
8. Haap M., Fritsche A., Mensing H.J., Haring H.U., Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003, 139:869-871.
9. Cooksey R.C., Jones D., Gabrielsen S., Huang J., Simcox J.A., Luo B., et al. Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep -/-) mouse. Am J Physiol Endocrinol Metab 2010, 298:1236-1243.
10. George D.K., Goldwurm S., MacDonald G.A., Cowley L.L., Walker N.I., Ward P.J., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998, 114:311-318.
11. Valenti L., Fracanzani A.L., Bugianesi E., Dongiovanni P., Galmozzi E., Vanni E., et al. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2010, 138:905-912.
12. Jehn M., Clark J.M., Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004, 27:2422-2428.
13. Tuomainen T.P., Nyyssonen K., Salonen R., Tervahauta A., Korpela H., Lakka T., et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997, 20:426-428.
14. Mendler M.H., Turlin B., Moirand R., Jouanolle A.M., Sapey T., Guyader D., et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999, 117:1155-1163.
15. Silvaa M., Silvaa M.E., de Paulaa H., Carneiroc C.M., Pedrosaa M.L. Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats. Nutr Res 2008, 28:391-398.
16. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to Ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
17. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044.
18. Chung B., Matak P., McKie A.T., Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007, 137:2366-2370.
19. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
20. Fernandex-Real J.M., Equitani F., Moreno J.M., Manco M., Ortega F., Ricart W. Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 2009, 94(3):982-988.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
22. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Med Sci 1959, 37:911-917.
24. Burant C.F., Sreenan S., Hirano K., Tai T.A., Lohmiller J., Lukens J., et al. Troglitazone action is independent of adipose tissue. J Clin Invest 1997, 100:2900-2908.
25. Kishimoto M., Endo H., Hagiwara S., Miwa A., Noda M. Immunohistochemical findinds in the pancreatic islets of a patient with transfusional iron overload and diabetes: case report. J Med Invest 2010, 57:345-349.
26. McClung J.P., Karl J.P. Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 2009, 67:100-104.
27. Pinhas-Hamiel O., Newfield R.S., Koren I., Agmon A., Lilos P., Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 2006, 27:416-418.
28. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009, 1790:682-693.
29. Hentze M.W., Muckenthaler M.U., Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004, 117:285-297.
30. Aigner E., Theurl I., Theurl M., Lederer D., Haufe H., Dietze O., et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 2008, 87:1374-1383.
31. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-7819.
32. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011, 434:365-381.
33. Dongiovanni P., Valenti L., Fracanzani A.L., Gatti S., Cairo G., Fargion S. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol 2008, 172:738-747.
34. Vaithilingama V., Oberholzerb J., Guilleminc G.J., Tuchd B.E. Beneficial effects of desferrioxamine on encapsulated human islets-in vitro and in vivo study. Am J Transplant 2010, 10:1961-1969.
35. Muoio D.M., Newgard C.B. Biomedicine, Insulin resistance takes a trip through the ER. Science 2004, 306:452-456.
36. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
37. Vecchi C., Montosi G., Zhang K., Lamberti L., Duncan S.A., Kaufman R.J., et al. ER stress controls iron metabolism through induction of hepcidin. Science 2009, 325:877-880.
38. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
39. Urakawa H., Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Morioka K., et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003, 88:4673-4676.
40. Jouihan H.A., Cobine P.A., Cooksey R.C., Hoagland E.A., Boudina S., Abel E.D., et al. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med 2008, 14:98-108.
41. Kulaksiz H., Fein E., Redecker P., Stremmel W., Adler G., Cetin Y. Pancreatic b-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol 2008, 197:241-249.